Evidence map›Paper›PMID 35036656›Full record

ArticleRomanian journal of ophthalmology

Use of plasma rich in growth factors (PRGF-Endoret®) fibrin membrane to cover corneal dellen.

Miriam Rahhal-Ortuño, Alex Samir Fernández-Santodomingo, Clara Martínez-Rubio, Honorio Barranco-González, Inmaculada Almor-Palacios, Ana Rodrigo-Hernández

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in Romanian journal of ophthalmology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Evaluation of Platelet-Rich Plasma by means of PRGFFrontiers in veterinary science · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Miriam Rahhal-OrtuñoDepartment of Ophthalmology, Hospital Universitari i Politecnic La Fe, Valencia, Spain.
Alex Samir Fernández-SantodomingoDepartment of Ophthalmology, Hospital Universitari i Politecnic La Fe, Valencia, Spain.
Clara Martínez-RubioDepartment of Ophthalmology, Hospital Universitari i Politecnic La Fe, Valencia, Spain.
Honorio Barranco-GonzálezDepartment of Ophthalmology, Hospital Universitari i Politecnic La Fe, Valencia, Spain.
Inmaculada Almor-PalaciosDepartment of Ophthalmology, Hospital Universitari i Politecnic La Fe, Valencia, Spain.
Ana Rodrigo-HernándezDepartment of Ophthalmology, Hospital Universitari i Politecnic La Fe, Valencia, Spain.
Hospital Universitari i Politècnic La Fe · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Corneal dellen appeared as a complication after perilimbal conjunctival papilloma dissection in a six-year-old patient. Our purpose was to describe the use of plasma rich in growth factors (PRGF) fibrin membrane in covering the corneal defect after conventional medical treatment failure. PRGF fibrin membrane is an interesting therapeutical option to consider not only in adult patients, but also in children.

Indexed as

FibrinIntercellular Signaling Peptides and ProteinsAdultChildConjunctivaHumansPlasmaFibrinIntercellular Signaling Peptides and ProteinsdellenpapillomaPlasma rich in growth factors

Identifiers

PMID35036656
PMCPMC8697786
OpenAlexW3206364649

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.